Biome Australia Limited (ASX:BIO) Reports Strong Q3 FY25 Sales Growth
Biome Australia (ASX:BIO) reports a 41% increase in Q3 FY25 sales revenue, highlighting strong growth and positive future outlook.
Biome Australia (ASX:BIO) reports a 41% increase in Q3 FY25 sales revenue, highlighting strong growth and positive future outlook.
Vulcan Energy (ASX:VUL) updates Phase One Project financing with potential German Raw Materials Fund participation and adjusts project timelines.
Vanguard Investments Australia Ltd (ASX:VIF) announces final distribution amounts and timetable for its ETFs.
Euro Manganese Inc. (ASX:EMN) announces a 5-for-1 share consolidation effective March 31, 2025, impacting its trading on TSXV and ASX.
Vanguard Investments Australia Ltd (ASX:VCF) announces final distribution amounts and timetable for its ETFs, effective April 2025.
Mesoblast (ASX:MSB) enters Medicaid agreement with CMS for Ryoncil®, enabling treatment for children with SR-aGvHD.
Andromeda Metals Limited (ASX:ADN) enters exclusive negotiations with Merricks Capital for A$75M debt financing to support the Great White Project.
Domain Holdings Australia (ASX:DHG) enters an exclusive acquisition agreement with CoStar Group for $4.43 per share.
Dreadnought Resources (ASX:DRE) raises $8.5 million through placement and a share purchase plan to advance its gold projects.
Chariot Corporation (ASX:CC9) amends its Black Mountain Purchase Option, extending payment terms and issuing 2 million shares.